(MENAFN- GetNews) The Key Retinal Vein Occlusion Companies in the market include - Taiwan Liposome Company, Aerie Pharmaceuticals, Graybug Vision, Outlook Therapeutics, Kodiak Sciences, Roche/Chugai ...

The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for Eylea for the treatment of visual impairment due to macular oedema, caused by retinal vein occlusion ...

The MHRA has granted marketing authorisation for Eylea ® (aflibercept 8 mg) for the treatment of patients with macular oedema following retinal vein occlusion (RVO) including branch, central and ...

Imran Khan Health Update: In a big update in the health conditions of former Pakistan Prime Minister Imran Khan, local Pakistani reports have conformed that the PTI leader will be taken to eye ...

Recent media reports from Pakistan suggest that Imran Khan, the former Prime Minister and World Cup-winning captain, has reportedly lost nearly 85% of vision in his right eye due to central retinal ...

Adults aged 55 years or less with sleep apnea have a higher cumulative incidence of retinal vein occlusion. Adults aged 55 years or younger with sleep apnea (SA) were found to be at increased risk for ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...

TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD ® (aflibercept) ...

High dose aflibercept may have applications for various subtypes of retinal vein occlusion. Treatment with high dose aflibercept 8 mg can lead to similar visual outcomes with fewer injections for ...